Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
12.02
-0.11 (-0.91%)
Nov 17, 2026, 3:00 PM CST
SHA:600161 Revenue
Beijing Tiantan Biological Products had revenue of 1.26B CNY in the quarter ending September 30, 2026, a decrease of -7.23%. This brings the company's total for the last twelve months to 5.56B, down -13.52% year-over-year. In the year 2025, Beijing Tiantan Biological Products had annual revenue of 6.17B with 2.26% growth. That makes Beijing Tiantan Biological Products the 8,520th largest company in the world by revenue and 1,307th in China.
Revenue (ttm)
5.56B
Revenue Growth
-13.52%
P/S Ratio
4.28
Revenue / Employee
1.07M
Employees
5,205
Market Cap
23.77B
Revenue by Geography
- China 6.15B 100.0%
- Overseas 1.62M 0.0%
Fiscal year ended Dec 31, 2025 See the full SHA:600161 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.17B | 136.17M | 2.26% |
| Dec 31, 2024 | 6.03B | 851.42M | 16.44% |
| Dec 31, 2023 | 5.18B | 919.14M | 21.57% |
| Dec 31, 2022 | 4.26B | 149.15M | 3.63% |
| Dec 31, 2021 | 4.11B | 666.56M | 19.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsBeijing Tiantan Biological Products News
- 19 days ago - Beijing Tiantan Biological Products Quarterly report: Q3 2026 - Filings
- 2 months ago - Beijing Tiantan Biological Products Quarterly report: H1 2026 - Filings
- 6 months ago - Beijing Tiantan Biological Products Quarterly report: Q1 2026 - Filings
- 7 months ago - Beijing Tiantan Biological Products Annual report: H2 2025 - Filings